xxxxxDNA
{"sector":"","industry":"","symbol":"DNA","company_name":"Genentech ","exchange":""}xxxxxDNA Articles
Underscoring just how much big pharma will depend on biotech acquisitions for future revenue, an analysis published by Evaluate Pharma today suggests half of the top 100 drugs worldwide by 2014 –...
Published:
Last Updated:
According to Reuters, Obama demanded that the G-20 find solutions to the global financial crisis. Reuters reports that a bankruptcy for GM (GM) and Chrysler could be a long, drawn-out process....
Published:
Last Updated:
According to Reuters, Obama may be stretched to thin. Reuters reports that AIG (AIG) executives in Europe are resisting returning bonuses. Reuters reports that Obama will begin to tighten the screws...
Published:
Last Updated:
If the rumor mill has any truth to it, then Allergan Inc. (NYSE: GSK) may by the next biotech takeover target. There is roughly $150 billion in new equity investor capital that can be put to work...
Published:
Last Updated:
The hope for a higher Genentech Inc. (NYSE: DNA) buyout price is getting smaller and smaller. After the companies agreed to a $95.00 per share merger, this was already assumed as the nearly certain...
Published:
Last Updated:
A large part of the money that was made by banks and investment banks from 2004 through most of 2007 was made from mergers and acquisitions. When the credit markets fell apart, the financing for...
Published:
Last Updated:
Before Roche decided to try to buy the 44% of biotech company Genentech (DNA) that it did not already own the smaller firm traded at $75. Roche offered just over $86 a share. Genentech said “no.”...
Published:
Last Updated:
According to Reuters, Roche agreed to buy Genentech (DNA) for $46.8 billion. Reuters reports that the world economy is shrinking as the G20 meeting approaches. Reuters reports that US foreclosure...
Published:
Last Updated:
According to the head of the FDIC, a “bad bank” system could jumpstart the US economy. Reuters reports that some economists believe that the US economy will start to rebound in the second half of...
Published:
Last Updated:
Roche has apparently capitulated in its fight to take over Genentech Inc. (NYSE: DNA). Its cancer franchise and its pipeline, along with a shareholder proxy fight, finally made Roche tip its...
Published:
Last Updated:
According to Reuters, too much dependence on government aid could cause a second recession when the companies are forced to stand on their own. Reuters reports that Obama is considering funds to buy...
Published:
Last Updated:
The board of Genentech (DNA) turned down an $86.50 offer by Roche to buy the part of the company that it does not already own. Until about a month ago, the offer had been higher–$89. The #1 Thing...
Published:
Last Updated:
According to Reuters, JPMorgan (JPM) cuts its dividend. Reuters reports that AIG (AIG) got bids from Met Life and Axa for its life unit. Reuters says that healthcare spending is taking a higher...
Published:
Last Updated:
According to Reuters, Honda (HMC) sales in the US fell in January. Reuters reports that the premier of China sees hopeful signs in his economy. Reuters reports that hard times make government jobs...
Published:
Last Updated:
According to Reuters, Republican may keep fighting Obama on the stimulus package. Reuters reports that Roche dropped its bid on Genentech (DNA) to $42 billion. Reuters writes that the Administration...
Published:
Last Updated: